• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS
  • Email newsletter

Pharma industry news

Probiodrug

Probiodrug raises €22.5 million in successful Initial Public Offering and listing on Euronext Amsterdam

Posted on: 24 October 2014 | Source: Probiodrug

Probiodrug AG announces the successful completion of its Initial Public Offering, which was launched on 10 October 2014 (the “IPO” or the “Offering”)...

Electrocore

Trial reported in Headache and Pain journal further confirms the effectiveness of electroCore’s non-invasive vagus nerve stimulation treatment for headache

Posted on: 24 October 2014 | Source: electroCore

Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes...

EMA

EMA ready to start assessment of Ebola vaccines and treatments as soon as data are made available

Posted on: 24 October 2014 | Source: European Medicines Agency

Rapid scientific advice to speed up development...

GlaxoSmithKline logo

Results announcement for the third quarter 2014

Posted on: 24 October 2014 | Source: GlaxoSmithKline

GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share...

GlobalData

Pharmaceutical industry feeling force of tax inversion legislation, says GlobalData Analyst

Posted on: 24 October 2014 | Source: GlobalData

The recent termination of AbbVie’s deal to acquire Shire makes this pharmaceuticals’ first major casualty of new US tax inversion legislation, and has jolted the industry out of its reverie, according to an analyst with research and consulting firm GlobalData...

Helsinn

Data presented at the International Society of Paediatric Oncology (SIOP) Congress show Palonosetron is a valuable option for treating pediatric patients receiving moderately to highly emetogenic chemotherapy

Posted on: 24 October 2014 | Source: Helsinn Group

Helsinn Group, the company focused on building quality cancer care, present data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 μg/kg, is a valuable and efficacious treatment option for chemotherapy-induced nausea and vomiting (CINV) in pediatric patients up to 17 years of age...

Medical Research Council logo

£230 million for technologies to revolutionise research into disease

Posted on: 23 October 2014 | Source: MRC Press Office

The Chancellor of the Exchequer, George Osborne, has announced that a partnership led by the Medical Research Council will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia, and dramatically speeding up diagnosis and treatment...

Cardio3 BioSciences (C3BS) Logo

Cardio3 Biosciences appoints Dr. Warren Sherman as Chief Medical Officer

Posted on: 23 October 2014 | Source: Cardio3 BioSciences

Cardio3 BioSciences announces the appointment of Dr. Warren Sherman as Chief Medical Officer, effective as of 1 November 2014...

Masters

Masters Speciality Pharma signs exclusivity agreement with Speciality European Pharma for the exclusive distribution of Mitocin®/Mitem® 20mg (mitomycin)

Posted on: 23 October 2014 | Source: Masters Speciality Pharma

Masters Speciality Pharma is pleased to announce a partnership agreement with Speciality European Pharma for the exclusive distribution of Mitocin®/Mitem® (mitomycin) to the Caribbean, Egypt, Kuwait, Iran, Saudi Arabia, UAE, Kenya, Seychelles, Uganda, Zimbabwe, Chile, Denmark, Greece, Ireland, Norway and Sweden...

Santen

Santen announces positive outcome of the European Decentralized Procedure for approval of TAPTIQOM®

Posted on: 23 October 2014 | Source: Santen

Santen GmbH. announced the positive outcome of the Decentralized Procedure (DCP) for TAPTIQOM® in Europe...

Frost & Sullivan

Public Health Sector offers immense opportunities for global wound care market

Posted on: 23 October 2014 | Source: Frost & Sullivan

Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies, says Frost & Sullivan...

Rotary

Rotary announces US$ 8.4 million in grants to fight polio in Nigeria

Posted on: 22 October 2014 | Source: Distributed by APO (African Press Organization) on behalf of Rotary International

With a 90 percent reduction in polio cases, Nigeria is close to ending transmission of the poliovirus...